U.S. Physical Therapy Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
11.0%projected annual EPS growth
Analyst Coverage
6analysts covering
FY Revenue (est.)
$846.3Mnext fiscal year
FY EPS (est.)
$2.89next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 4 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Total Net Revenue Quarterly198.3M
Adjusted EBITDA Quarterly20.2MTarget: 102000000 to 106000000
Average Daily Visits per Clinic Quarterly31.8
Net Rate per Physical Therapy Visit Quarterly10,649.0%
Watch Items
- Medicare Reimbursement Rate AdjustmentsTrigger: Deviation from the expected 1.75% MPFS rate increaseAction: Re-evaluate clinic-level operating margins and adjust therapist staffing models to offset reimbursement shortfalls.
- Hospital Strategic Alliance RolloutTrigger: Delay in operationalizing the 60 Metro clinics with the New York hospital system by year-end 2026Action: Assess sequential quarterly revenue contribution and adjust full-year EBITDA run-rate expectations.
- Labor Cost Inflation and Therapist WagesTrigger: Adjusted physical therapy payroll cost per visit exceeding $65.00Action: Implement cost-control measures, optimize clinic utilization, and accelerate transition to higher-margin private insurance payers.
Research as of 19 Jun 2026